Preventive effect of selenium pretreatment against cisplatin-induced oral mucositis in rats
Journal: The European Research Journal (Vol.3, No. 1)Publication Date: 2017-03-04
Authors : Sedat Dogan; Hasmet Yazici; Esin Yalcinkaya; Halil Ibrahim Erdogdu;
Page : 11-15
Keywords : Cisplatin; oral mucositis; selenium; toxicity References;
Abstract
Objective. The aim of the present study was to investigate the protective role of selenium against cisplatin-induced oral mucositis in rats. Methods. Healthy wistar albino rats (n=21) were randomly divided into three groups: Cisplatin (Cis), cisplatin and selenium (Cis+Se) and control (C). Cisplatin was administered for 3 days to Cis and Cis+Se groups. Cis+Se group received selenium 5 days before cisplatin injection and continued for 11 consecutive days. Malondialdehyde (MDA) levels of the rats were determined before and at the end of experimental protocol. The tongues of rats were harvested for immunuhistochemical examinations. Results. In biochemichal analysis, MDA levels significantly increased in the Cis group (p=0.018). On the contrary, there was no significant difference between pretreatment and posttreatment MDA levels in Cis+Se group (p=0.128). In the immunohistochemical examinations of lingual tissues stained with anti-caspase-3, when the Cis and Cis+Se groups were compared, there were significantly more immunopositivity in the Cis group and significantly less immunopositivity in the Cis+Se group (p<0.05). Conclusions. Selenium might have played a protective role against cisplatin-induced oral mucositis in rats. Further studies are necessary before its clinical use in patients.
Other Latest Articles
- Nonapoptotic cell death induced by Hypericum species on cancer cells
- ASSOCIATION OF CALOT’S TRIANGLE CYSTIC LYMPH NODE AND CYSTIC ARTERY DURING LAPAROSCOPIC CHOLECYSTECTOMY
- FREQUENCY OF CARDIAC COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT TERTIARY CARE HOSPITAL
- ANEMIA IN CHILDREN WITH PALMAR PALLOR AGED 02 MONTHS TO 05 YEARS
- MATRIX TABLET OF RASAGILINE MESYLATE: AN APPROACH FOR THE TREATMENT OF PARKINSON DISEASE
Last modified: 2017-03-06 02:58:44